microRNA-802 is involved in palmitate-induced damage to pancreatic β cells through repression of sirtuin 6
Related Experiment Video
Updated: Dec 30, 2025

Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes
Published on: June 25, 2017
Ning Lin1, Yixin Niu1, Weiwei Zhang1
1Department of Endocrinology, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai, China.
Abstract:
Free fatty acid (FFA)-induced pancreatic β-cell loss is implicated in the pathogenesis of type 2 diabetes mellitus (T2DM). It has been documented that circulating microRNA (miR)-802 levels are significantly greater in T2DM patients than in healthy subjects. However, the role of miR-802 in FFA-induced damage to β cells is still unclear. In the present study, we measured the expression of miR-802 in the INS-1 rat insulinoma cell line after palmitate treatment for 48 h. Gain- and loss-of-function studies were conducted to determine the function of miR-802 in palmitate-induced apoptosis and reactive oxygen species (ROS) production. The target gene(s) of miR-802 was functionally characterized. Compared to control cells, palmitate treatment caused a time- and concentration-dependent induction of miR-802 in INS-1 cells. Knockdown of miR-802 significantly blocked palmitate-induced apoptosis and attenuated ROS formation. Moreover, miR-802 downregulation prevented the reduction of prosurvival proteins Mcl-1 and Bcl-xL by palmitate. In contrast, ectopic expression of miR-802 stimulated apoptosis and ROS generation in INS-1 cells. Sirtuin 6 (SIRT6) was identified to be a direct target gene of miR-802. Overexpression of miR-802 suppressed the expression of SIRT6. Enforced expression of SIRT6 abolished the induction of apoptosis and ROS production by miR-802. Taken together, miR-802 is required for palmitate-induced damage to β cells by targeting SIRT6 and represents a potential therapeutic target for T2DM.
Insights
MicroRNA-802 (miR-802) exacerbates free fatty acid damage to pancreatic beta cells, a key factor in type 2 diabetes. Inhibiting miR-802 protects these cells by targeting SIRT6, offering a potential therapeutic strategy for T2DM.
Area of Science:
- Endocrinology
- Molecular Biology
- Cell Biology
Background:
- Free fatty acid (FFA) excess contributes to pancreatic beta-cell dysfunction and loss, a hallmark of type 2 diabetes mellitus (T2DM).
- Elevated circulating microRNA-802 (miR-802) levels are observed in T2DM patients, but its specific role in FFA-induced beta-cell damage remains elusive.
Purpose of the Study:
- To investigate the role of miR-802 in free fatty acid (palmitate)-induced damage to pancreatic beta cells.
- To identify the molecular mechanisms and therapeutic potential of targeting miR-802 in the context of T2DM pathogenesis.
Main Methods:
- Palmitate treatment of INS-1 rat insulinoma cells to induce FFA damage.
- miR-802 expression analysis, gain- and loss-of-function studies.
- Assessment of apoptosis, reactive oxygen species (ROS) production, and protein levels (Mcl-1, Bcl-xL, SIRT6).
Main Results:
- Palmitate treatment increased miR-802 expression in INS-1 cells in a time- and concentration-dependent manner.
- miR-802 knockdown protected beta cells from palmitate-induced apoptosis and ROS generation, preserving prosurvival proteins.
- miR-802 directly targets Sirtuin 6 (SIRT6), and its overexpression suppressed SIRT6, leading to increased apoptosis and ROS.
Conclusions:
- miR-802 is essential for palmitate-induced beta-cell damage by downregulating SIRT6.
- Targeting miR-802 presents a promising therapeutic avenue for T2DM by protecting pancreatic beta cells from lipotoxicity.
More Related Videos
08:40Visualization of Endogenous Mitophagy Complexes In Situ in Human Pancreatic Beta Cells Utilizing Proximity Ligation Assay
Published on: May 2, 2019
12:32High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds
Published on: January 23, 2018
Related Concept Videos
MicroRNAs
MicroRNAs
PI3K/mTOR/AKT Signaling Pathway